Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government ...
While Merck reported strong financial results in recent quarters, it faces both upsides and risks in the future. Read why I'm ...
In a meeting on Monday, Merck Sharp & Dohme LLC proposed a substantial $900 million biologics manufacturing facility in ...
As part of the Fund's increased transparency, the tentative calendar of the formal meetings and seminars of the Executive Board for the next seven days is shown below. Please note that the calendar is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results